# Safety and Efficacy of Nerinetide (NA-1) in Subjects Undergoing Endovascular Thrombectomy for Stroke

Study · id `cardio:ct-nct02930018` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02930018](<https://clinicaltrials.gov/study/NCT02930018>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02930018

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1105 participants.

## Technical summary

Registry record NCT02930018. Randomized; quadruple masking; primary purpose treatment. Start 2017-03-01 (actual); primary completion 2019-11-20 (actual). Results posted on 2020-12-14.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 1105 participants (enrolled count; ClinicalTrials.gov record NCT02930018, source copy `cardio:ctgov-nct02930018-2022-10-10`, retrieved 2026-10-26)
- Started: 2017-03-01 (actual) (ClinicalTrials.gov record NCT02930018, source copy `cardio:ctgov-nct02930018-2022-10-10`, retrieved 2026-10-26)
- Primary completion: 2019-11-20 (actual) (ClinicalTrials.gov record NCT02930018, source copy `cardio:ctgov-nct02930018-2022-10-10`, retrieved 2026-10-26)
- Completion: 2019-11-20 (actual) (ClinicalTrials.gov record NCT02930018, source copy `cardio:ctgov-nct02930018-2022-10-10`, retrieved 2026-10-26)
- Results first posted: 2020-12-14 (ClinicalTrials.gov record NCT02930018, source copy `cardio:ctgov-nct02930018-2022-10-10`, retrieved 2026-10-26)
- Countries: United States; Australia; Canada; Germany; Ireland; South Korea; Sweden; United Kingdom (ClinicalTrials.gov record NCT02930018, source copy `cardio:ctgov-nct02930018-2022-10-10`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02930018-2022-10-10`, retrieved 2026-10-26)

## The registry's words

- Brief title: Safety and Efficacy of Nerinetide (NA-1) in Subjects Undergoing Endovascular Thrombectomy for Stroke
- Acronym: ESCAPE-NA1
- Condition: Stroke, Acute
- Intervention (Drug): Nerinetide (NA-1), 2.6 mg/kg
- Intervention (Drug): Placebo
- Lead sponsor: NoNO Inc.
- Lead sponsor class: INDUSTRY
- Collaborator: University of Calgary
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: NoNO Inc. (`cardio:org-nono-inc`)
- Registry lists this organization as a collaborator: University of Calgary (`cardio:org-university-of-calgary`)

### Other papers using this trial's data

- Registry lists this paper as a reference of type result; PubMed dates it on or after the trial start and types it as a trial report, neither its types nor its title mark it as a protocol, a review or a comment, the paper names no other trial in place of this one, and PubMed shows no retraction or expression of concern; it is not marked as the trial's main report: Efficacy and safety of nerinetide for the treatment of acute ischaemic stroke (ESCAPE-NA1): a multicentre, double-blind, randomised controlled trial (`cardio:pubmed-32087818`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Infarcts in a New Territory: Insights From the ESCAPE-NA1 Trial (`cardio:pubmed-37082967`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Infarct Evolution on MR-DWI After Thrombectomy in Acute Stroke Patients Randomized to Nerinetide or Placebo: The REPERFUSE-NA1 Study (`cardio:pubmed-38165335`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Factors Influencing Nerinetide Effect on Infarct Volume in Patients Without Alteplase in the Randomized ESCAPE-NA1 Trial (`cardio:pubmed-39648909`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Association of baseline infarct size, reperfusion grade and intracranial hemorrhage in patients undergoing thrombectomy (`cardio:pubmed-40122606`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 056dabf66f5ebfb4b261cc2c86e2df1fa717cca0a159d8907167d6ca0c39c161
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
